Senseera
Ronen Sadeh is a seasoned professional in the biochemistry and epigenomics fields, currently serving as Co-Founder and CEO at Senseera since August 2020. Prior to this role, Ronen held the position of Senior Research Associate at The Hebrew University of Jerusalem from June 2013 to 2021. Academic qualifications include a Postgraduate Degree in Epigenomics from The Rockefeller University, completed in May 2013, alongside a Doctor of Philosophy in Biochemistry and a Master of Science in Biochemistry, both obtained from the Technion - Israel Institute of Technology between 2000 and 2008.
This person is not in any teams
This person is not in any offices
Senseera
We are developing a liquid biopsy blood test for early detection and monitoring of a broad spectrum of human diseases. We use molecular biology, next generation sequencing, and advanced computational analysis to extract rich epigenetic information encoded in chromatin fragments circulating in the blood and transform it into concrete clinical information.